Insulin detemir
Alternative Names: Levemir
Levemir (insulin detemir) is a long-acting basal insulin used to manage blood sugar in people with type 1 and type 2 diabetes. It has a relatively smooth and prolonged action, typically lasting up to 20–24 hours, though some people may need twice-daily dosing for full coverage. Levemir begins working about 1–2 hours after injection and has no pronounced peak, helping to reduce the risk of low blood sugar. It is commonly used alongside mealtime (bolus) insulin or oral diabetes medications. Levemir is delivered by subcutaneous injection and is available in vials or prefilled pens.
Treatment Type: Prescription Medication
Treatment Class: N/A
Treatment Modality: N/A
Review Summary
Based on the provided information, there are no user reviews available for the treatment "Insulin detemir" against the disease "Diabetes, Type 1". Without any reviews or ratings, it is not possible to determine the effectiveness of this treatment for Type 1 Diabetes based solely on the given data. More information and user experiences are needed to provide a meaningful summary of the treatment's efficacy.
This summary was generated by users' reviews
Breakdown by Category
Each categories are rated on a 1–5 scale, with 5 being the most favorable outcome and 1 being the least. These scores are averaged across all user reviews to provide a clear sense of how this treatment typically performs in each area.
Explore various treatment options to empower yourself in making a well-informed choice.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
Choose treatments from the menu above to see how they compare side by side.
AI Summary of User Experiences
Not medical advice.
Based on the provided information, there are no user reviews available for the treatment "Insulin detemir" against the disease "Diabetes, Type 1". Without any reviews or ratings, it is not possible to determine the effectiveness of this treatment for Type 1 Diabetes based solely on the given data. More information and user experiences are needed to provide a meaningful summary of the treatment's efficacy.
No reviews yet.
Be the first to share your experience with this treatment. Your insights help others make informed decisions about their care.
Reviews
Filter by reviewer type Pro